GB0714941D0 - Inhibitors - Google Patents
InhibitorsInfo
- Publication number
- GB0714941D0 GB0714941D0 GBGB0714941.2A GB0714941A GB0714941D0 GB 0714941 D0 GB0714941 D0 GB 0714941D0 GB 0714941 A GB0714941 A GB 0714941A GB 0714941 D0 GB0714941 D0 GB 0714941D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0714941.2A GB0714941D0 (en) | 2007-08-01 | 2007-08-01 | Inhibitors |
PCT/GB2008/002616 WO2009016384A2 (en) | 2007-08-01 | 2008-07-31 | Gsk-3 inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0714941.2A GB0714941D0 (en) | 2007-08-01 | 2007-08-01 | Inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0714941D0 true GB0714941D0 (en) | 2007-09-12 |
Family
ID=38529084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0714941.2A Ceased GB0714941D0 (en) | 2007-08-01 | 2007-08-01 | Inhibitors |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0714941D0 (en) |
WO (1) | WO2009016384A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110305706A1 (en) | 2009-02-23 | 2011-12-15 | Scott Thomas Brady | Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010052137A1 (en) * | 2000-03-01 | 2001-12-13 | Trustees Of The University Of Pennsylvania | Axin domain-like polypeptide inhibitors of glycogen synthase kinase 3 beta activity and activators of wnt signaling |
US20050164324A1 (en) * | 2003-06-04 | 2005-07-28 | Gygi Steven P. | Systems, methods and kits for characterizing phosphoproteomes |
AU2005234687A1 (en) * | 2003-06-27 | 2005-12-08 | Tel Aviv Universtiy Future Technology Development L.P. | Glycogen Synthase Kinase-3 Inhibitors |
GB0418328D0 (en) * | 2004-08-17 | 2004-09-22 | Imp College Innovations Ltd | Cancer methods and medicaments |
-
2007
- 2007-08-01 GB GBGB0714941.2A patent/GB0714941D0/en not_active Ceased
-
2008
- 2008-07-31 WO PCT/GB2008/002616 patent/WO2009016384A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009016384A3 (en) | 2009-04-09 |
WO2009016384A2 (en) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1700018I1 (en) | Proteasome inhibitors | |
HK1176601A1 (en) | Ire-1a inhibitors ire-1a | |
IL201379A0 (en) | Inhibitors iap | |
DK200800103A (en) | Integreret føringskant for vindturbineblad | |
IL200779A0 (en) | Pdgfr beta-specific inhibitors | |
EP2200439A4 (en) | Hdac inhibitors | |
EP2272817A4 (en) | Pai-1 inhibitor | |
ZA201100898B (en) | Novel inhibitors | |
GB0719997D0 (en) | Portease Inhibition | |
ZA201102837B (en) | Phosphodiestarase inhibitors | |
EP2222662A4 (en) | Kynurenine-aminotransferase inhibitors | |
EP2177529A4 (en) | Novel -secretase inhibitor | |
GB0714941D0 (en) | Inhibitors | |
GB0713152D0 (en) | Phosphodlesterase inhibitors | |
GB0707497D0 (en) | Novel inhibitors | |
GB0707632D0 (en) | Novel inhibitors | |
GB0704589D0 (en) | Novel inhibitors | |
GB0707488D0 (en) | Novel inhibitors | |
GB0707498D0 (en) | Novel inhibitors | |
GB0707499D0 (en) | Novel inhibitors | |
GB0707495D0 (en) | Novel inhibitors | |
GB0707493D0 (en) | Novel inhibitors | |
GB0720364D0 (en) | Inhibitor | |
GB201019387D0 (en) | Inhibitors | |
GB0816125D0 (en) | Novel inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |